Skip to main content
eScholarship
Open Access Publications from the University of California

Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo.

  • Author(s): Mobasher, P
  • Guerra, R
  • Li, SJ
  • Frangos, J
  • Ganesan, AK
  • Huang, V
  • et al.

Published Web Location

https://doi.org/10.1111/bjd.18606
Main Content
Current View